Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens-Reference-Cited by-同舟云学术

Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens

Published:1996-12 Issue:6 Volume:62 Page:1659-1667
ISSN:0003-4975
Container-title:The Annals of Thoracic Surgery
language:en
Short-container-title:The Annals of Thoracic Surgery

Author:

Lemmer John H.,Dilling Emery W.,Morton Jeremy R.,Rich Jeffrey B.,Robicsek Francis,Bricker Donald L.,Hantler Charles B.,Copeland Jack G.,Ochsner John L.,Daily Pat O.,Whitten Charles W.,Noon George P.,Maddi Rosemarie

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference24 articles.

1. Bidstrup BP, Royston DM, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high-dose aprotinin (Trasylol). J Thorac Cardiovasc Surg 1989;97:364–72.

2. Cosgrove DM, Heric B, Lytle BW, et al. Aprotinin therapy for reoperative myocardial revascularization: a placebo-controlled study. Ann Thorac Surg 1992;54:1031–8.

3. Lemmer JH Jr, Stanford W, Bonney SL, et al. Aprotinin for coronary bypass operations: efficacy, safety, and influence on early saphenous vein graft patency. J Thorac Cardiovasc Surg 1994;107:543–53.

4. Davis R, Whittington R. Aprotinin: a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery. Drugs 1995;49:954–83.

5. Schönberger JPAM, Everts PAM, Ercan H, et al. Low-dose aprotinin in internal mammary artery bypass operations contributes to important blood saving. Ann Thorac Surg 1992;54:1172–6.

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies to attenuate maladaptive inflammatory response associated with cardiopulmonary bypass;Frontiers in Surgery;2024-07-03

2. Cost analysis study comparing the impact of treatment with aprotinin versus tranexamic acid in cardiac surgery under cardiopulmonary bypass;Annales Pharmaceutiques Françaises;2024-07

3. Use of Aprotinin versus Tranexamic Acid in Cardiac Surgery Patients with High-Risk for Excessive Bleeding (APACHE) trial: a multicentre retrospective comparative non-randomized historical study;European Journal of Cardio-Thoracic Surgery;2024-01-05

4. Antifibrinolytics and cardiac surgery: The past, the present, and the future;Annals of Cardiac Anaesthesia;2020

5. Aprotinin in adults at high risk of major blood loss during isolated CABG with cardiopulmonary bypass: a profile of its use in the EU;Drugs & Therapy Perspectives;2019-11-11